Although several recurrent genetic aberrations are known to occur in MALT lymphoma, no comprehensive study on the most prevalent MALT lymphoma-associated genetic aberrations is available. We therefore screened 252 primary MALT lymphomas for translocations t(11;18)(q21;q21), t(14;18) (q32;q21), and t(1;14)(p22;q32), and trisomies 3 and 18. The above-listed translocations occurred mutually exclusively and were detected overall in 13.5, 10.8, and 1.6% of the cases; trisomy 3 and/or 18 occurred in 42.1%. The frequency at which the translocations occurred varied markedly with the primary site of disease. The t(11;18)(q21;q21) was mainly detected in pulmonary and gastric tumors, whereas the t(14;18)(q32;q21) was most commonly found in lesions of the ocular adnexa/ orbit, skin, and salivary glands. Trisomies 3 and 18 each occurred most frequently in intestinal and salivary gland MALT lymphomas. Our results demonstrate that the three translocations and trisomies 3 and 18 occur at markedly variable frequencies in MALT lymphoma of different sites.
Introduction
Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) is listed as a distinct clinicopathologic entity in the WHO classification of malignant lymphomas. 1 The majority of MALT lymphomas occur in the stomach, but this type of lymphoma may affect virtually every organ in the human body, including the ocular adnexa and orbit, lung, salivary glands, thyroid, skin, and intestine. 2 Histologically, MALT lymphomas are characterized by a proliferation of neoplastic marginal zone-related cells that invade epithelial structures to generate lymphoepithelial lesions and colonize reactive lymphoid follicles. 3 The MALT lymphoma concept suggests that these tumors correspond to cells of postfollicular differentiation stages and usually arise from lymphoid tissue acquired by chronic antigenic stimulation triggered by persistent infections and/or autoimmune processes. 4, 5 One of the most interesting aspects of MALT lymphoma is the accumulating evidence of microbial agents involved in its pathogenesis. The first to be reported has been the association of Helicobacter pylori with gastric disease, 6 followed by the linkeage of Borrelia burgdorferi with cutaneous tumors, 7 then almost simultaneously the association of Chlamydia psittaci with ocular adnexal MALT lymphoma and of Campylobacter jejuni with a extremely rare variant of MALT lymphoma known as immunoproliferative small intestinal disease (IPSID), respectively. 8, 9 This acquired lymphoid tissue becomes genetically unstable with the acquisition of structural abnormalities such as t(1;14)(p22;q32), 10 t(11;18)(q21;q21), 11, 12 and the most recently described t(14;18)(q32;q21) involving the immunoglobulin heavy chain locus (IGH) and MALT1, 13 as well as numerical aberrations such as trisomy 3 and trisomy 18, 14 leading to transformation into MALT lymphoma. The specific events responsible for the genetic aberration(s) remain to be discovered and, with the exception of the t(11;18)(q21;q21), which fuses the amino terminal of the API2 gene to the carboxyl terminal of the MALT1 gene generating a chimeric API2-MALT1 fusion transcript, 15 the true incidence of these genetic abnormalities is unknown. In order to evaluate the overall frequency and the frequency relative to lymphoma site, we analyzed a large series of MALT lymphomas for the above-mentioned translocations and the numerical aberrations þ 3 and þ 18.
Patients and methods

Patient selection
The study group comprised 252 MALT lymphoma cases derived from the primary site of disease presentation. Formalin-fixed and paraffin-embedded tissue samples of biopsies or surgical resection specimens were retrieved from the authors' institutions. For inclusion in this study, the cases were required to fulfill the histologic and immunohistologic criteria defined for MALT lymphoma in the WHO classification of tumors of hematopoietic and lymphoid tissues. 1 Furthermore, the cases were selected for the amount of tumor tissue sufficient for reverse transcriptase polymerase chain reaction (RT-PCR) and fluorescence in situ hybridization (FISH) studies. The immunophenotype of the tumor cells, as assessed on paraffin sections, was CD20 þ , cyclin D1À, CD23À, CD5À, bcl-6À, and CD10À. Among the 252 MALT lymphoma cases, 71 cases were from the stomach; 51 from the skin; 42 from the salivary glands; 37 arose from the ocular adnexa/orbit; 16 from the intestine (small intestine, n ¼ 5; large intestine, n ¼ 11); 15 from the lung; six from the thyroid; five from the breast; four each from the liver and urogenital tract; and one from the sphenoorbital region.
The presence of tumor cells was evaluated in each tissue block on hematoxylin and eosin-stained slides cut before and after the sections used for FISH or RT-PCR analyses. Data on 75 patients have been part of previous publications. 13, [16] [17] [18] Detection of t(11;18) by RT-PCR RNA was isolated from archival formalin-fixed, paraffinembedded lymphoma tissues. Total RNA was extracted from 10 mm sections with a high pure RNA paraffin kit (Roche Diagnostics, Mannheim, Germany). First-strand cDNA was synthesized from 1 mg total RNA with a superscript first-strand synthesis system (Invitrogen, Carlsbad, CA, USA) using random hexamers as primers. RT-PCR for the detection of the API2-MALT1 fusion transcript was performed according to Inagaki et al, 19 with one modification: first round RT-PCR products were amplified in a second round separately and not as multiplex nested PCRs in order to discriminate the various fusion signals. Where indicated PCR products were sequenced using dRhodamine dye terminators on an ABI Prism 310 (PE Applied Biosystems, Foster City, CA, USA).
FISH analysis
In all 252 cases, formalin-fixed paraffin-embedded tissue was used for FISH. For a reliable interpretation of the hybridization signals, we preferred the analysis of single-cell suspensions to thin sections. FISH was performed on interphases with the following probe sets: for the detection of the t(14;18)(q32;q21) involving IGH and MALT1, P1 artificial chromosome (PAC) 152M5 (SpectrumOrange labeled) spanning the MALT1 gene and flanking regions and bacterial artificial chromosome (BAC) 158A2 were used; 13 for rearrangements of BCL10, BACs RP11-1077C10 and RP11-36L4 (SpectrumGreen) centromeric to BCL10 and RP11-1080I1 and RP11-40K4 (SpectrumOrange) telomeric to BCL10 were used. 20 In cases with rearrangement of BCL10, FISH with a dual-color, break apart rearrangement probe for IGH (Vysis, Downer's Grove, IL) was performed; FISH with BAC 158A2 for IGH and BACs RP11-1080I1 and RP11-40K4 telomeric to BCL10 were used to confirm the t(1;14)(p22;q32). For the detection of trisomies 3 and 18, we applied centromere-specific probes for the chromosomes 3 (SpectrumOrange) and 18 (SpectrumGreen) (Vysis).
The cutoff value for the diagnosis of each probe set was the mean percentage of cells with a false-positive signal constellation plus 3 standard deviations, as assessed on tissue from 20 reactive lymph nodes.
Results
The t(11;18)(q21;q21) and the t(14;18)(q32;q21) occurred at markedly variable frequencies in MALT lymphomas of different sites
The RT-PCR and FISH results are summarized in Table 1 and schematically illustrated in Figure 1 . Among the 252 MALT lymphomas, 34 (13.5%) were positive for t(11;18)(q21;q21). This finding was confirmed by FISH as all of these 34 cases exhibited a split signal for MALT1, but no IGH/MALT1 fusion signals. Conversely, FISH did not identify a t(11;18)(q21;q21) þ case among those tested negative by RT-PCR, indicating 100% concordance of the two techniques. Furthermore, in the translocation-positive cases, two normal signals were generated for BCL10, centromere 3 and centromere 18, indicating that the t(11;18)(q21;q21) did not occur in combination with either t(14;18)(q32;q21) or BCL10 rearrangement or any of the two trisomies. The t(11;18)(q21;q21) was found at the highest frequencies in MALT lymphomas derived from the lung (53.3%) and stomach (23.9%), and at a moderate frequency in those from the intestine (12.5%). The translocation was seen in 7.8% of cutaneous MALT lymphomas and in only one lymphoma each of salivary gland (2.4%) and ocular adnexa/ orbit (2.7%), but was absent in tumors arising in the breast, liver, and urogenital tract.
The distribution of breakpoints in both the API2 and MALT1 genes among MALT lymphomas of different sites was similar (data not shown) and also similar to those reported. 20 The t(14;18)(q32;q21) was identified in 27 (10.8%) of the 252 cases and, as already reported, was detected in all four hepatic MALT lymphomas analyzed. 13 Among the more common sites at which MALT lymphomas arise, the translocation was found in lesions of the ocular adnexa/orbit (24.3%), skin (13.7%), salivary gland (11.9%), and lung (6.7%), but was absent in the intestine, breast, urogenital tract, and thyroid. In a series of MALT lymphomas occurring in patients with Sjö gren's syndrome, we have recently reported on the first patient with a t(14;18)(q32;q21) þ gastric MALT lymphoma, 18 who is included in the present work. This patient was staged extensively according to Raderer et al, 16 without evidence of extragastric disease at presentation and at 2 years of follow-up. Separated In an additional case, MALT1 amplification was detected.
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MALT1 signals and hence MALT1 gene rearrangement were confined to cases with either t(11;18)(q21;q21) or t(14;18) (q32;q21), indicating that these two translocations represent the main structural aberrations involving MALT1.
t(1;14)(p22;q32) is exceedingly rare in MALT lymphoma BCL10 rearrangement was found in only four of the 252 cases (1.6%) and IGH at band 14q32 represented the translocation partner in all cases. Two of the MALT lymphomas harboring the t(1;14)(p22;q32) arose from the rectum and sigmoid colon, respectively, and were thus detected in 13% of the intestinal tumors; the remaining two cases derived from the lung and parotid gland. No amplification of BCL10 was observed.
Trisomy 3 and trisomy 18 occur at markedly variable frequencies in MALT lymphomas of different sites
Trisomy 3 was observed in 30.9% of the cases and most frequently occurred in MALT lymphomas of the intestine (75%), salivary gland (54.8%), lung (20%), and skin (19.6%). The overall incidence of trisomy 18 was lower (11.2%) and this aberration occurred most frequently in MALT lymphomas of the intestine (25%) and salivary gland (19%).
Discussion
MALT lymphoma represents one of the most common B-cell neoplasms and arises by definition at an extranodal site. As a distinct disease entity listed in the WHO classification, the definition of MALT lymphoma is supposed to be a combination of morphology, immunophenotype, genetic, and clinical features. Among the genetic aberrations reported to occur in MALT lymphoma, the three translocations t(1;14)(p22;q32), 10 t(11;18)(q21;q21), 11, 12 and t(14;18)(q32;q21) 13 are of particular importance because they appear to be specific for or at least closely associated with the disease. The t(11;18)(q21;q21) has been studied extensively in gastric MALT lymphoma and recently a large series of MALT lymphomas has been screened for the translocation, providing important information on its frequency at the less common extragastric sites. 20 The major goal of the present study for the first time was to analyze a large series of MALT lymphomas of different sites for all the three MALT lymphoma-associated structural aberrations, that is, t(11;18)(q21;q21), t(14;18)(q32;q21), and t(1;14)(p22;q32), and to additionally screen for the most common numerical aberrations, that is, trisomy 3 and trisomy 18.
In the larger series of gastric MALT lymphoma, t(11;18)(q21;q21) was found in 14-48% of the cases. [21] [22] [23] [24] [25] In the largest series of 138 cases reported to date, Ye et al 20 detected the API2-MALT1 fusion transcript at exactly the same 23.9% as in our study. The detection of the t(11;18)(q21;q21) in gastric MALT lymphoma is clinically important as most translocation-positive tumors do not respond to H. pylori eradication therapy, are associated with more advanced stage of disease, and usually do not transform into aggressive lymphoma. [26] [27] [28] [29] The single t(14;18)(q32;q21) þ gastric MALT lymphoma represents the first case reported to carry this aberration within the gastrointestinal tract. Nevertheless, this finding confirms previous studies and indicates that the t(14;18)(q32;q21) is virtually absent among primary gastrointestinal MALT lymphomas. 13, 22 The MALT lymphoma-specific t(1;14)(p22;q32) causes deregulation of BCL10, 30,31 which specifically links the antigen Figure 1 Graphical demonstration of frequencies of t(11;18)(q21;q21), t(14;18)(q32;q21), t(1;14)(p22;q32), and trisomies 3 and/or 18 in 252 MALT lymphomas. Please note that the numbers given for trisomies 3/18 refer to cases that carry this aberration only, that is, are negative for any of the three translocations. For clarity, the data on trisomies 3 and 18 were combined. The frequencies of the trisomies 3 and 18 are shown separately in Table 1 . 32 In contrast to normal lymphoid cells and to MALT lymphomas negative for the t(1;14)(p22;q32), MALT lymphomas harboring the t(1;14)(p22;q32) typically show high nuclear BCL10 expression. 33 By screening 331 MALT lymphomas immunohistochemically for BCL10 expression, Ye et al identified 12 cases (3.6%) comprising six gastric, five pulmonary, and one cutaneous MALT lymphoma, and confirmed the rearrangement of BCL10 by FISH in five of seven cases tested. 20 Our molecular cytogenetic study revealed BCL10 rearrangement in four of 252 cases (1.6%), two of which occurred in the colorectum and one each in the lung and salivary gland, respectively. The reason why none of our gastric MALT lymphomas harbored the t(1;14)(p22;q32) is not clear.
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Cutaneous MALT lymphoma, also referred to as cutaneous marginal zone B-cell lymphoma, has been evaluated for the t(11;18)(q21;q21), but so far no positive case has been reported, including the larger series comprising 27, 24, and 12 cases, respectively. 20, 34, 35 We found the translocation in four of 51 cases (7.8%), suggesting that it does occur in cutaneous MALT lymphomas, albeit at low frequency. The t(14;18)(q32;q21) was detected slightly more often (13.7%) and, because the two translocations always occur mutually exclusively, one or the other was found in 21.6% of the cases.
Among salivary gland MALT lymphomas, the t(11;18) (q21;q21) is exceptionally rare. By combining the results of our and the two other larger studies, only two of 144 cases tested positive. 20, 22 By contrast, the t(14;18)(q32;q21) was found in roughly 12% in our series and in six of 28 cases (21.4%) in another study, 22 reflecting our experience of an opposite frequency of the two translocations at a given site. To the best of our knowledge, the single t(1;14)(p22;q32) þ MALT lymphoma represents the first case arising at this site which, according to the negative results of the BCL10 expression study, 20 appears to be exceptional.
Similar to most other nongastric MALT lymphomas, those arising at the ocular adnexa (conjunctiva, lacrimal gland, and orbit) have not been studied genetically, except for the t(11;18)(q21;q21), providing somewhat conflicting results. Ye et al 20 detected the t(11;18)(q21;q21) in nine of 55 cases (16.3%), whereas Adachi et al 36 reported on 51 cases, all of which were negative and therefore closely resembled our findings with only one of 37 tumors positive. We do provide evidence, however, that among the prototypical MALT lymphoma sites tumors arising at the ocular adnexa/orbit are those that most often harbor the t(14;18)(q32;q21), as detected in almost a quarter (24.3%) of the cases studied herein.
All 16 intestinal MALT lymphomas harbored at least one of the five aberrations examined, among which trisomy 3 and/or 18 were most prevalent, occurring in 13 of the 16 cases (81.5%), and might be regarded as a genetic hallmark of the disease. Conversely, we detected the t(11;18)(q21;q21) in only two of the 16 primary intestinal MALT lymphomas. Interestingly, Ye et al 1, 20 did not find the translocation in any of their 22 cases of immunoproliferative small intestinal disease (IPSID), which by definition arises in the intestine and represents a variant of MALT lymphoma.
In agreement with previous studies showing that the t(11;18)(q21;q21) is most commonly detected in pulmonary MALT lymphomas with frequencies ranging from 25 to 41%, 20, 37, 38 we found the API2-MALT1 fusion transcript in even 53.5% of these cases. The occurrence of the t(11;18)(q21;q21) in gastric MALT lymphoma has been linked hypothetically to oxidative damage caused predominantly by CagA-positive strains of Helicobacter pylori. 20 A similar etiology involving a hitherto unidentified pathogen is conceiveable in t(11;18)(q21;q21)-positive pulmonary MALT lymphoma. 20 This hypothesis is supported by the recent observation that t(11;18)(q21;q21)-positive pulmonary MALT lymphoma is not associated with autoimmune disease. 37 Our data confirm that the t(14;18)(q32;q21) and the t(1;14)(p22;q32) occur at low frequency in pulmonary MALT lymphoma. 20, 38 Nevertheless, MALT lymphoma arising at this site is somewhat exceptional, as this tumor may carry any of the three translocations, and, by combining their frequencies (66.7% in our study), is by far the most 'translocation-prone' MALT lymphoma.
Among the few MALT lymphoma cases arising at the thyroid, breast, liver, urogenital tract, and the sphenoorbital region, the hepatic cases stand out because of the close association with the t(14;18)(q32;q21). 13 Aneuploidy, most commonly trisomy 3 and/or trisomy 18, frequently occurs in MALT lymphoma, but may also be detected in other B-cell lymphomas, albeit at a much lower frequency. 14, 39, 40 The high frequency of trisomy 3 in MALT lymphoma, particularly in tumors arising from the intestine, salivary glands, and ocular adnexa, suggests that one or more genes at chromosome 3 are involved in the pathogenesis of these neoplasms.
In summary, our results demonstrate that the three translocations t(11;18)(q21;q21), t(14;18)(q32;q21), and t(1;14)(p22;q32), and the trisomies 3 and/or 18, occur at markedly variable frequencies in MALT lymphoma of different sites. The genetic data have to be correlated with clinical findings such as stage of disease, response to treatment, and disease recurrence, in order to evaluate their predictive value. The notion that a high proportion of MALT lymphomas is negative for any of the abovementioned aberrations should encourage future research.
